{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:22:38Z","timestamp":1771593758495,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.labinv.2024.102073","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T16:18:29Z","timestamp":1715012309000},"page":"102073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pathological and Biological Significance of the Specific Glycan, TRA-1-60, on Aggressive Gastric Adenocarcinoma"],"prefix":"10.1016","volume":"104","author":[{"given":"Ayaka","family":"Mitsui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Iioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujiro","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kurose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schopperle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakiyo","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2939-036X","authenticated-orcid":false,"given":"Eisaku","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2024.102073_bib1","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1172\/JCI76094","article-title":"Targeting cancer with kinase inhibitors","volume":"125","author":"Gross","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.labinv.2024.102073_bib2","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.3390\/ijms19113491","article-title":"Receptor tyrosine kinase-targeted cancer therapy","volume":"19","author":"Yamaoka","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.labinv.2024.102073_bib3","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1172\/JCI57152","article-title":"Targeted therapies for breast cancer","volume":"121","author":"Higgins","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.labinv.2024.102073_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-021-00470-8","article-title":"Unlocking the potential of antibody-drug conjugates for cancer therapy","volume":"18","author":"Drago","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.labinv.2024.102073_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(19)31774-X","article-title":"Antibody\u2013drug conjugates for cancer","volume":"394","author":"Chau","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.labinv.2024.102073_bib6","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1158\/1078-0432.CCR-19-0272","article-title":"Antibody\u2013drug conjugates: future directions in clinical and translational strategies to improve the therapeutic index","volume":"25","author":"Coats","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.labinv.2024.102073_bib7","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/glycob\/cwq209","article-title":"The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency-associated type 1 lactosamine epitope","volume":"21","author":"Natnen","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.labinv.2024.102073_bib8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nbt.1580","article-title":"Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells","volume":"27","author":"Chan","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.labinv.2024.102073_bib9","doi-asserted-by":"crossref","first-page":"12172","DOI":"10.1073\/pnas.1310291110","article-title":"Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts","volume":"110","author":"Tanabe","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.labinv.2024.102073_bib10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.neo.2019.09.003","article-title":"PODXL1 promotes metastasis of the pancreatic ductal adenocarcinoma by activating the C5aR\/C5a axis from the tumor microenvironment","volume":"21","author":"Saito","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.labinv.2024.102073_bib11","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.7150\/thno.78915","article-title":"Selective ablation of TRA-1-60+ pluripotent stem cells suppresses tumor growth of prostate cancer","volume":"13","author":"White","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.labinv.2024.102073_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/cas.13870","article-title":"Identification of TRA-1-60-positive cells as a potent refractory population in follicular lymphomas","volume":"110","author":"Takata","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.labinv.2024.102073_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1634\/stemcells.2005-0597","article-title":"The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma","volume":"25","author":"Schopperle","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.labinv.2024.102073_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/bjc.2013.314","article-title":"CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence","volume":"109","author":"Hirata","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.labinv.2024.102073_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/bjc.2016.401","article-title":"Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer","volume":"116","author":"Kodama","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.labinv.2024.102073_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbrc.2020.11.024","article-title":"Hepatoprotective effect of apolipoprotein A4 against carbon tetrachloride-induced acute liver injury through mediating hepatic antioxidant and inflammation response in mice","volume":"534","author":"Li","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.labinv.2024.102073_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101178","article-title":"Intestinal fatty acid binding protein: a rising therapeutic target in lipid metabolism","volume":"87","author":"Huang","year":"2022","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.labinv.2024.102073_bib25","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.015002","article-title":"PRAP1 is a novel lipid-binding protein that promotes lipid absorption by facilitating MTTP-mediated lipid transport","volume":"296","author":"Peng","year":"2021","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.labinv.2024.102073_bib26","first-page":"2255","article-title":"ALDOB plays a tumor-suppressive role by inhibiting AKT activation in gastric cancer","volume":"14","author":"Peng","year":"2023","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.labinv.2024.102073_bib27","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.3390\/molecules25153337","article-title":"Perspectives for new and more efficient multifunctional ligands for Alzheimer\u2019s disease therapy","volume":"25","author":"Zagorska","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.labinv.2024.102073_bib28","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2741\/3818","article-title":"Modulation of signaling between TM4SF5 and integrins in tumor microenvironment","volume":"16","author":"Lee","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.labinv.2024.102073_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12885-016-2460-5","article-title":"Metalloproteases meprin-\u0251 (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.labinv.2024.102073_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.721252","article-title":"Antioxidant gene signature impacts the immune infiltration and predicts the prognosis of kidney renal clear cell\u00a0carcinoma","volume":"12","author":"Ren","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.labinv.2024.102073_bib31","doi-asserted-by":"crossref","first-page":"68412","DOI":"10.18632\/oncotarget.12032","article-title":"Dual oxidase 2 and pancreatic adenocarcinoma: IFN-\u03b3-mediated dual oxidase 2 overexpression results in H2O2-induced, ERK-associated up-regulation of HIF-1\u03b1 and VEGF-A","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.labinv.2024.102073_bib32","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1074\/jbc.M110.191031","article-title":"Up-regulation and sustained activation of Stat1 are essential for interferon-gamma (IFN-gamma)-induced dual oxidase 2 (Duox2) and dual oxidase A2 (DuoxA2) expression in human pancreatic cancer cell lines","volume":"286","author":"Wu","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.labinv.2024.102073_bib33","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.labinv.2024.102073_bib34","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/1097-0142(19930815)72:4<1308::AID-CNCR2820720426>3.0.CO;2-V","article-title":"Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis","volume":"72","author":"Giwercman","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.labinv.2024.102073_bib35","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1172\/JCI42059","article-title":"Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients","volume":"120","author":"Glynn","year":"2010","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.labinv.2024.102073_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/s12967-022-03716-w","article-title":"Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1\u03b1 signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy","volume":"20","author":"Zuo","year":"2022","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.labinv.2024.102073_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12032-014-0181-7","article-title":"Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinoma","volume":"31","author":"Qin","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.labinv.2024.102073_bib38","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1038\/onc.2012.638","article-title":"Redox regulation in stem-like cancer cells by CD44 variant isoforms","volume":"32","author":"Nagano","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.labinv.2024.102073_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00281-008-0118-3","article-title":"Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane","volume":"30","author":"El-Benna","year":"2008","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.labinv.2024.102073_bib40","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41467-022-29018-9","article-title":"Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis","volume":"13","author":"Wu","year":"2022","journal-title":"Nat Commun"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683724017513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683724017513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:56:56Z","timestamp":1721131016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683724017513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0023683724017513"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2024.102073","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathological and Biological Significance of the Specific Glycan, TRA-1-60, on Aggressive Gastric Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2024.102073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"102073"}}